litlas
Log inCreate account

Louis Boon

Active 2000–2025

171
Papers
20,347
Citations
88
h-index
164
i10-index

Citations

Citations per year for Louis Boon1997: 1 citations2001: 12 citations2002: 17 citations2003: 18 citations2004: 13 citations2005: 29 citations2006: 28 citations2007: 30 citations2008: 76 citations2009: 112 citations2010: 117 citations2011: 130 citations2012: 177 citations2013: 151 citations2014: 239 citations2015: 255 citations2016: 283 citations2017: 303 citations2018: 293 citations2019: 792 citations2020: 965 citations2021: 1,087 citations2022: 953 citations2023: 778 citations2024: 1,194 citations2025: 649 citations2026: 24 citations1998–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,644 citing papers, 21.2% of this breakdownChina: 1,948 citing papers, 15.6% of this breakdownGermany: 861 citing papers, 6.9% of this breakdownUnited Kingdom: 765 citing papers, 6.1% of this breakdownNetherlands: 694 citing papers, 5.6% of this breakdownItaly: 470 citing papers, 3.8% of this breakdownFrance: 448 citing papers, 3.6% of this breakdownAustralia: 373 citing papers, 3% of this breakdownBelgium: 346 citing papers, 2.8% of this breakdownJapan: 321 citing papers, 2.6% of this breakdownCanada: 318 citing papers, 2.5% of this breakdownSwitzerland: 312 citing papers, 2.5% of this breakdown
0%21.2%Other 23.8%

Institutions

Fields

  • Immunology and Microbiology37.9%
  • Medicine34.8%
  • Biochemistry, Genetics and Molecular Biology15.7%
  • Neuroscience6.2%
  • Engineering1.3%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Other3.1%

Topics

  • Immune Cell Function and Interaction6.2%
  • Immunotherapy and Immune Responses5.7%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Immune cells in cancer4.2%
  • T-cell and B-cell Immunology4%
  • Psoriasis: Treatment and Pathogenesis3.2%
  • Other72.2%

Coauthors

All papers

Open in search
  1. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

    Authors: Leslie van der Fits, Sabine Mourits, Jane S.A. Voerman, Marius Kant, Louis Boon, Jon D. Laman, Ferry Cornelissen, Anne‐Marie Mus, Edwin F. Florencia, Errol P. Prens, Erik Lubberts - The Journal of Immunology 2009 cited by 2,135

  2. The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

    Authors: Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, Melanie Lukkes, Larissa Klaase, Thierry van den Bosch, Menno van Nimwegen, Sai Ping Lau, Kitty Latupeirissa, Sjoerd Schetters, Yvette van Kooyk, Louis Boon, Antien Moyaart, Yvonne M. Mueller, Peter D. Katsikis, Alexander M.M. Eggermont, Heleen Vroman, Ralph Stadhouders, Rudi W. Hendriks, Jan H. von der Thüsen, Dirk J. Grünhagen, Cornelis Verhoef, Thorbald van Hall, Joachim G.J.V. Aerts - Cancer Cell 2020 cited by 668

  3. Aryl hydrocarbon receptor control of a disease tolerance defence pathway

    Authors: Alban Bessede, Marco Gargaro, Maria Teresa Pallotta, Davide Matino, Giuseppe Servillo, Cinzia Brunacci, Silvio Bicciato, Emilia Maria Cristina Mazza, Antonio Macchiarulo, Carmine Vacca, Rossana G. Iannitti, Luciana Tissi, Claudia Volpi, Maria Laura Belladonna, Ciriana Orabona, Roberta Bianchi, Tobias V. Lanz, Michael Platten, Maria Agnese Della Fazia, Danilo Piobbico, Teresa Zelante, Hiroshi Funakoshi, Toshikazu Nakamura, David Gilot, Michael S. Denison, Gilles J. Guillemin, James B. DuHadaway, George C. Prendergast, Richard Metz, M. Geffard, Louis Boon, Matteo Pirro, Alfonso Iorio, B. Veyret, Luigina Romani, Ursula Grohmann, Francesca Fallarino, Paolo Puccetti - Nature 2014 cited by 674

  4. Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

    Authors: Helena Van Damme, Bruno Dombrecht, Máté Kiss, Heleen Roose, Elizabeth Allen, Eva Van Overmeire, Daliya Kancheva, Liesbet Martens, Aleksandar Murgaski, Pauline M. R. Bardet, Gillian Blancke, Maude Jans, Evangelia Bolli, Maria Solange Martins, Yvon Elkrim, James Dooley, Louis Boon, Julia Katharina Schwarze, Frank Tacke, Kiavash Movahedi, Niels Vandamme, Bart Neyns, Sebahat Ocak, Isabelle Scheyltjens, Lars Vereecke, Frank Aboubakar Nana, Pascal Merchiers, Damya Laoui, Jo A. Van Ginderachter - Journal for ImmunoTherapy of Cancer 2021 cited by 202

  5. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

    Authors: Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters, Mike Eterman, Marit J van Elsas, Joanne M. Mankor, Larissa Klaase, Marjolein J. W. de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F. J. van IJcken, Louis Boon, Johan M. S. van der Schoot, Martijn Verdoes, Ferenc A. Scheeren, Sjoerd H. van der Burg, Bart N. Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim G.J.V. Aerts, Thorbald van Hall - Science Immunology 2023 cited by 99

  6. SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses

    Authors: Anthos Christofides, Xanthi-Lida Katopodi, Carol Cao, Dimitra Karagkouni, Konstantinos Aliazis, Sasitorn Yenyuwadee, Halil‐Ibrahim Aksoylar, Rinku Pal, Mohamed A. A. Mahmoud, Laura Strauss, Natalia M. Tijaro-Ovalle, Louis Boon, John M. Asara, Ioannis S. Vlachos, Nikolaos Patsoukis, Vassiliki A. Boussiotis - Nature Immunology 2022 cited by 89

  7. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity

    Authors: Christian Büll, Thomas J. Boltje, Natasja Balneger, Sarah Weischer, Melissa Wassink, Jasper J. van Gemst, Victor R. L. J. Bloemendal, Louis Boon, Johan van der Vlag, Torben Heise, Martijn H. den Brok, Gosse J. Adema - Cancer Research 2018 cited by 276

  8. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

    Authors: Maria Teresa Pallotta, Ciriana Orabona, Claudia Volpi, Carmine Vacca, Maria Laura Belladonna, Roberta Bianchi, Giuseppe Servillo, Cinzia Brunacci, Mario Calvitti, Silvio Bicciato, Emilia Maria Cristina Mazza, Louis Boon, Fabio Grassi, Maria C. Fioretti, Francesca Fallarino, Paolo Puccetti, Ursula Grohmann - Nature Immunology 2011 cited by 690

  9. LXR signaling controls homeostatic dendritic cell maturation

    Authors: Victor Bosteels, Sandra Maréchal, Clint De Nolf, Sofie Rennen, Jonathan Maelfait, Simon J. Tavernier, Jessica Vetters, Evelien Van De Velde, Farzaneh Fayazpour, Kim Deswarte, Alexander Lamoot, Julie Van Duyse, Liesbet Martens, Cédric Bosteels, Ria Roelandt, Annelies Emmaneel, Sofie Van Gassen, Louis Boon, Gert Van Isterdael, Isabelle Guillas, Niels Vandamme, Doris Höglinger, Bruno G. De Geest, Wilfried Le Goff, Yvan Saeys, Kodi S. Ravichandran, Bart N. Lambrecht, Sophie Janssens - Science Immunology 2023 cited by 101

  10. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication

    Authors: Marco Gargaro, Giulia Scalisi, Giorgia Manni, Carlos G. Briseño, Prachi Bagadia, Vivek Durai, Derek J. Theisen, Sun Kyung Kim, Marilena Castelli, Chenling Xu, Gerd Meyer zu Hörste, Giuseppe Servillo, Maria Agnese Della Fazia, Giulia Mencarelli, Doriana Ricciuti, Eleonora Padiglioni, Nicola Giacchè, Carolina Colliva, Roberto Pellicciari, Mario Calvitti, Teresa Zelante, Dietmar Fuchs, Ciriana Orabona, Louis Boon, Alban Bessede, Marco Colonna, Paolo Puccetti, Theresa L. Murphy, Kenneth M. Murphy, Francesca Fallarino - Immunity 2022 cited by 115

  11. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages

    Authors: Emmanuelle Alaluf, B. Vokaer, Aurélie Detavernier, Abdulkader Azouz, Marion Splittgerber, Alice Carrette, Louis Boon, Frédérick Libert, Miguel P. Soares, Alaín Le Moine, Stanislas Goriely - JCI Insight 2020 cited by 89

  12. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity

    Authors: Damya Laoui, Jiri Keirsse, Yannick Morias, Eva Van Overmeire, Xenia Geeraerts, Yvon Elkrim, Máté Kiss, Evangelia Bolli, Qods Lahmar, Dorine Sichien, Jens Serneels, Charlotte L. Scott, Louis Boon, Patrick De Baetselier, Massimiliano Mazzone, Martin Guilliams, Jo A. Van Ginderachter - Nature Communications 2016 cited by 269

  13. Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation

    Authors: Natalia Pikor, Jillian L. Astarita, Leslie Summers-Deluca, Georgina Galicia, Joy Qu, Lesley A. Ward, Susan Armstrong, Claudia X. Dominguez, Deepali Malhotra, Brendan T. Heiden, Robert Kay, Valera Castanov, Hanane Touil, Louis Boon, Paul O’Connor, Amit Bar‐Or, Alexandre Prat, Valeria Ramaglia, Samuel K. Ludwin, Shannon J. Turley, Jennifer L. Gommerman - Immunity 2015 cited by 225

  14. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

    Authors: Tom Seijkens, Claudia M. van Tiel, Pascal Kusters, Dorothee Atzler, Oliver Soehnlein, Barbara Zarzycka, Suzanne A. B. M. Aarts, Marnix Lameijer, Marion J. Gijbels, Linda Beckers, Myrthe den Toom, Bram Slütter, Johan Kuiper, Johan Duchêne, Maria Aslani, Remco T. A. Megens, Cornelis van ′t Veer, Gijs Kooij, Roy Schrijver, Marten A. Hoeksema, Louis Boon, François Fay, Jun Tang, Samantha Baxter, Aldo Jongejan, Perry D. Moerland, Gert Vriend, Boris Bleijlevens, Edward A. Fisher, Raphaël Duivenvoorden, Norbert Gerdes, Menno P.J. de Winther, Gerry A. F. Nicolaes, Willem J. M. Mulder, Christian Weber, Esther Lutgens - Journal of the American College of Cardiology 2018 cited by 194

  15. Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment

    Authors: Rachael M. Zemek, Emma de Jong, Wee Loong Chin, Iona S. Schuster, Vanessa S. Fear, Thomas Casey, Cath Forbes, Sarah Dart, Connull Leslie, Ayham Zaitouny, Michael Small, Louis Boon, Alistair R. R. Forrest, Daithi O. Muiri, Mariapia A. Degli‐Esposti, Michael Millward, Anna K. Nowak, Timo Lassmann, Anthony Bosco, Richard Lake, W. Joost Lesterhuis - Science Translational Medicine 2019 cited by 216

  16. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development

    Authors: Athina Varveri, Miranta Papadopoulou, Zacharias Papadovasilakis, Ewoud B. Compeer, Aigli‐Ioanna Legaki, Anastasios Delis, Vasileia Damaskou, Louis Boon, Sevasti Papadogiorgaki, Martina Samiotaki, Periklis Foukas, Aristides G. Eliopoulos, Aikaterini Hatzioannou, Themis Alissafi, Michael L. Dustin, Panayotis Verginis - Nature Communications 2024 cited by 60

  17. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

    Authors: Abhishek D. Garg, Lien Vandenberk, Carolien Koks, Tina Verschuere, Louis Boon, Stefaan Van Gool, Patrizia Agostinis - Science Translational Medicine 2016 cited by 267

  18. Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis

    Authors: Brecht Steelant, Sven Seys, Laura Van Gerven, Matthias Van Woensel, Ricard Farré, Paulina Wawrzyniak, Inge Kortekaas Krohn, Dominique Bullens, Karel Talavera, Ulrike Raap, Louis Boon, Cezmi A. Akdiş, Guy E. Boeckxstaens, Jan Ceuppens, Peter W. Hellings - Journal of Allergy and Clinical Immunology 2017 cited by 239

  19. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells

    Authors: Aoife McGinley, Caroline E. Sutton, Sarah C. Edwards, Charlotte M. Leane, Joseph DeCourcey, Ana Teijeiro, John A. Hamilton, Louis Boon, Nabil Djouder, Kingston H. G. Mills - Immunity 2020 cited by 245

  20. An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion

    Authors: Aikaterini Hatzioannou, Aggelos Banos, Theodore Sakelaropoulos, Constantinos Fedonidis, Maria-Sophia Vidali, Maren Köhne, Kristian Händler, Louis Boon, Ana Henriques, Vasiliki Koliaraki, Panagiotis Georgiadis, Jérôme Zoidakis, Aikaterini Termentzi, Marc Beyer, Triantafyllos Chavakis, Dimitrios T. Boumpas, Aristotelis Tsirigos, Panayotis Verginis - Nature Immunology 2019 cited by 133

  21. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage

    Authors: Patricia Aparicio‐Domingo, Mónica Romera‐Hernández, Julien J. Karrich, Ferry Cornelissen, Natalie Papazian, Dicky J. Lindenbergh-Kortleve, James A. Butler, Louis Boon, Mark Coles, Janneke N. Samsom, Tom Cupedo - The Journal of Experimental Medicine 2015 cited by 190

  22. IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D

    Authors: Máté Kiss, Lieselotte Vande Walle, Pedro Saavedra, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, Jiri Keirsse, Pauline M. R. Bardet, Sana M. Arnouk, Yvon Elkrim, Maryse Schmoetten, Jan Brughmans, Ayla Debraekeleer, Amelie Fossoul, Louis Boon, Geert Raes, Geert Loo, Diether Lambrechts, Massimiliano Mazzone, Alain Beschin, Andy Wullaert, Mohamed Lamkanfi, Jo A. Van Ginderachter, Damya Laoui - Cancer Immunology Research 2020 cited by 95

  23. Enteric glial cells favor accumulation of anti-inflammatory macrophages during the resolution of muscularis inflammation

    Authors: Michelle Stakenborg, Saeed Abdurahiman, Veronica De Simone, Gera Goverse, Nathalie Stakenborg, Lies van Baarle, Qin Wu, Dimitri Pirottin, Jung‐Seok Kim, Louise Chappell‐Maor, Isabel Pintelon, Sofie Thys, Emilie Pollenus, Louis Boon, Philippe E. Van den Steen, Marlene M. Hao, Jo A. Van Ginderachter, Guy E. Boeckxstaens, Jean‐Pierre Timmermans, Steffen Jung, Thomas Marichal, Sales Ibiza, Gianluca Matteoli - Mucosal Immunology 2022 cited by 52

  24. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

    Authors: Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer - Scientific Reports 2017 cited by 141